120 related articles for article (PubMed ID: 18054939)
1. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
[TBL] [Abstract][Full Text] [Related]
2. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
[TBL] [Abstract][Full Text] [Related]
3. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
[TBL] [Abstract][Full Text] [Related]
4. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
[TBL] [Abstract][Full Text] [Related]
5. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
[TBL] [Abstract][Full Text] [Related]
6. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
Pesonen U; Koch W; Schömig A; Kastrati A
J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
[TBL] [Abstract][Full Text] [Related]
7. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
[TBL] [Abstract][Full Text] [Related]
8. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
[TBL] [Abstract][Full Text] [Related]
9. High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.
Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Dehghan-Manshadi R; Forghanifard MM; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M
Gene; 2012 Mar; 496(1):22-7. PubMed ID: 22289186
[TBL] [Abstract][Full Text] [Related]
10. The hepatic lipase gene C-480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study.
Fan YM; Lehtimäki T; Rontu R; Ilveskoski E; Goebeler S; Kajander O; Mikkelsson J; Viiri LE; Perola M; Karhunen PJ
Eur J Clin Invest; 2007 Jun; 37(6):472-7. PubMed ID: 17537154
[TBL] [Abstract][Full Text] [Related]
11. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
[TBL] [Abstract][Full Text] [Related]
12. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease.
Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Manshadi RD; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M
Angiology; 2013 Jan; 64(1):40-5. PubMed ID: 22308535
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
[TBL] [Abstract][Full Text] [Related]
15. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704
[TBL] [Abstract][Full Text] [Related]
16. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
[TBL] [Abstract][Full Text] [Related]
17. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men.
Kunnas TA; Ilveskoski E; Niskakangas T; Laippala P; Kajander OA; Mikkelsson J; Goebeler S; Penttilä A; Perola M; Nikkari ST; Karhunen PJ
J Mol Med (Berl); 2002 Sep; 80(9):605-9. PubMed ID: 12226742
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
Hernesniemi JA; Karhunen PJ; Oksala N; Kähönen M; Levula M; Rontu R; Ilveskoski E; Kajander O; Goebeler S; Viiri LE; Hurme M; Lehtimäki T
Eur Heart J; 2009 Dec; 30(23):2939-46. PubMed ID: 19687159
[TBL] [Abstract][Full Text] [Related]
19. Association of paraoxonase-1 M55L genotype and alcohol consumption with coronary atherosclerosis: the Helsinki Sudden Death Study.
Rontu R; Lehtimäki T; Ilveskoski E; Mikkelsson J; Kajander O; Goebeler S; Perola M; Penttilä A; Karhunen PJ
Pharmacogenetics; 2004 Aug; 14(8):479-85. PubMed ID: 15284530
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
